Profil
Daniel A. Simon is Chief Business Officer at IDEAYA Biosciences, Inc. since 2024.
Formerly, Chief Business Officer at Revolution Medicines, Inc. from 2022 to 2024.
Senior VP-Biopharma Business Development at Guardant Health, Inc. from 2015 to 2022.
Education includes graduate studies at the University of Cambridge and an MBA from The Wharton School of the University of Pennsylvania.
Aktiva positioner av Daniel Simon
| Företag | Position | Start |
|---|---|---|
| IDEAYA BIOSCIENCES, INC. | Företagsledare/Principal | 2024-08-01 |
Tidigare kända positioner av Daniel Simon
| Företag | Position | Slut |
|---|---|---|
| REVOLUTION MEDICINES, INC. | Företagsledare/Principal | 2024-01-01 |
| GUARDANT HEALTH, INC. | Företagsledare/Principal | 2022-01-01 |
Daniel Simons utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Guardant Health, Inc.
Guardant Health, Inc. Medical SpecialtiesHealth Technology Develops blood and tissue test devices to detect cancer & provides related screening services | Health Technology |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revolution Medicines, Inc.
Revolution Medicines, Inc. Pharmaceuticals: OtherHealth Technology Develops new therapies derived from natural products | Health Technology |
IDEAYA Biosciences, Inc.
IDEAYA Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as oncology-focused precision medicine company which develops and sells cancer therapeutics | Health Technology |
















